Table 3. Ranking of the indices of insulin release according to their rank sums.
Overall ranking(all SNPs tested) | Ranking for detection of GSIS(MTNR1B, HHEX, and CDKAL1 SNPs) | Ranking for detection of ISIS(TCF7L2, WFS1, and KCNQ1 SNPs) | ||||||
Rank | Parameter | Rank sum (from lsn) | Rank | Parameter | Rank sum (from lsn) | Rank | Parameter | Rank sum (from lsn) |
1 | AUCInsulin(0-30)/AUCGlucose(0-30) | 24* | 1 | AUCInsulin(0-30)/AUCGlucose(0-30) | 7 | 1 | AUCC-Peptide(0-120)/AUCGlucose(0-120) | 6 |
2 | CIR | 28* | 2 | CIR | 10 | 2 | AUCC-Peptide(0-30)/AUCGlucose(0-30) | 9 |
3 | AUCC-Peptide(0-30)/AUCGlucose(0-30) | 29* | 3 | IGI2 | 13 | 3 | C-Peptide 30 min | 14 |
AUCC-Peptide(0-120)/AUCGlucose(0-120) | 29* | 4 | First-phase insulin secretion | 16 | 4 | IGI1 | 17 | |
5 | IGI2 | 33* | 5 | Insulin 30 min | 17 | AUCInsulin(0-30)/AUCGlucose(0-30) | 17 | |
6 | IGI1 | 36* | 6 | IGI1 | 19 | 6 | CIR | 18 |
7 | C-Peptide 30 min | 39 | 7 | AUCC-Peptide(0-30)/AUCGlucose(0-30) | 20 | 7 | IGI2 | 20 |
8 | Insulin 30 min | 42* | 8 | AUCC-Peptide(0-120)/AUCGlucose(0-120) | 23 | 8 | AUCInsulin(0-120)/AUCGlucose(0-120) | 22 |
First-phase insulin secretion | 42 | 9 | AUCInsulin(0-120)/AUCGlucose(0-120) | 24 | 9 | Insulin 30 min | 25 | |
10 | AUCInsulin(0-120)/AUCGlucose(0-120) | 46 | 10 | C-Peptide 30 min | 25 | 10 | First-phase insulin secretion | 26 |
11 | DI oral | 55 | DI oral | 25 | 11 | DI oral | 30 | |
12 | HOMA-β | 64 | 12 | HOMA-B | 34 | HOMA-B | 30 |
Significantly different from HOMA-B (p<0.05; Wilcoxon rank sum test). AUC – area under the curve; CIR – cleared insulin response; DI – disposition index; GSIS – glucose-stimulated insulin secretion; HOMA-B – homeostasis model assessment of beta-cell function; IGI – insulinogenic index; ISIS – incretin-stimulated insulin secretion/incretin production; lsn – least significant number; SNP – single nucleotide polymorphism.